Related Experiment Videos

Soluble factors from murine and human tumors induce suppressor cells

Insights

Tumor-derived suppressor factor (TDSF) isolated from mouse fibrosarcoma enhances tumor growth by inducing suppressor cells. This factor inhibits cell-mediated immunity in mice and humans, impacting cancer progression.

Area of Science:

  • Immunology
  • Oncology
  • Biochemistry

Background:

  • Tumor-derived suppressor factor (TDSF) plays a role in immune evasion.
  • Understanding TDSF's mechanism is crucial for cancer therapy.

Purpose of the Study:

  • To isolate and characterize TDSF from murine fibrosarcoma.
  • To investigate TDSF's effect on immune cells and tumor growth.

Main Methods:

  • Preparative isoelectric focusing to isolate TDSF.
  • Incubation of TDSF with normal spleen cells.
  • Chemical characterization including heat, RNase, trypsin, DNase, pronase, and neuraminidase treatments.
  • High-performance gel permeation chromatography for molecular weight determination.

Main Results:

  • TDSF isolated from murine fibrosarcoma enhances tumor growth and inhibits delayed-type hypersensitivity (DTH).
  • Suppressogenic activity detected in various murine and human tumor extracts, but not in normal cells.
  • TDSF is sensitive to heat and RNase, partially sensitive to trypsin, and resistant to DNase, pronase, and neuraminidase.
  • Apparent molecular weight of TDSF is >300 kDa.

Conclusions:

  • Acidic soluble factors from tumors induce suppressor cells that inhibit cell-mediated immunity.
  • TDSF represents a significant factor in tumor-induced immunosuppression.
  • Further research into TDSF could lead to novel cancer treatment strategies.

Related Concept Videos